A safety and immunogenicity study of immunization with hVEGF26-104/RFASE in cynomolgus monkeys.
Sign Up to like & getrecommendations! Published in 2018 at "Vaccine"
DOI: 10.1016/j.vaccine.2018.02.066
Abstract: INTRODUCTION Vascular endothelial growth factor (VEGF) is pivotal in tumor angiogenesis and therapies targeting the VEGF axis are widely used in the clinic for the treatment of cancer. We have developed a therapeutic vaccine targeting… read more here.
Keywords: rfase; immunization; hvegf26 104; immunogenicity ... See more keywords